Norman Putzki
Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study
Pardini M, Putzki N, Tettenborn B, Valmaggia C, Würfel J, Gass A, Kuhle J, Vehoff J, Müller S, Botzkowski D, Yaldizli O (2015). Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study.
07.10.2015Brain metabolites and retinal nerve fibre layer thickness and their relation to disability in multiple sclerosis: a longitudinal high-field proton magnetic resonance spectroscopy and optical coherence tomography study
07.10.2015ECTRIMS 2015
Pardini M., Putzki Norman, Tettenborn Barbara, Valmaggia Christophe, Würfel Jens, Gass Andrea, Kuhle Jens, Vehoff Jochen, Müller Stefanie, Botzkowski D., Yaldizli Ozgür
Fatigue and progression of corpus callosum atrophy in multiple sclerosis
Yaldizli O, Glassl S, Sturm D, Papadopoulou A, Gass A, Tettenborn B, Putzki N. Fatigue and progression of corpus callosum atrophy in multiple sclerosis. J Neurol 2011; 258:2199-205.
19.05.2011Fatigue and progression of corpus callosum atrophy in multiple sclerosis
19.05.2011J Neurol 2011; 258:2199-205
Yaldizli Ozgür, Glassl Stephanie, Sturm Dietrich, Papadopoulou Athina, Gass Achim, Tettenborn Barbara, Putzki Norman
Vitamin D levels in Swiss multiple sclerosis patients
Tettenborn B, Yildiz M, Putzki N. Vitamin D levels in Swiss multiple sclerosis patients. Swiss Med Wkly 2011
03.05.2011Vitamin D levels in Swiss multiple sclerosis patients
03.05.2011Swiss Med Wkly 2011
Tettenborn Barbara, Yildiz Murat, Putzki Norman
Vitamin D levels in Swiss multiple sclerosis patients
Yildiz M, Tettenborn B, Putzki N. Vitamin D levels in Swiss multiple sclerosis patients. Swiss Med Wkly 2011; 141:w13192.
03.05.2011Vitamin D levels in Swiss multiple sclerosis patients
03.05.2011Swiss Med Wkly 2011; 141:w13192
Yildiz Murat, Tettenborn Barbara, Putzki Norman
Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon-beta and glatiramer acetate
Yildiz M, Tettenborn B, Putzki N. Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon-beta and glatiramer acetate. Eur Neurol 2011; 65:231-2.
31.03.2011Multiple sclerosis-associated fatigue during disease-modifying treatment with natalizumab, interferon-beta and glatiramer acetate
31.03.2011Eur Neurol 2011; 65:231-2
Yildiz Murat, Tettenborn Barbara, Putzki Norman
Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate
Yildiz M, Tettenborn B, Putzki N (2010). Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate.
13.10.2010Multiple sclerosis associated fatigue during disease modifying treatment with natalizumab, interferon-beta and glatirameracetate
13.10.2010ECTRIMS
Yildiz Murat, Tettenborn Barbara, Putzki Norman
Natalizumab and beyond
Yildiz M, Tettenborn B, Putzki N. Natalizumab and beyond. Eur Neurol 2010; 64:236-40.
04.09.2010Natalizumab and beyond
04.09.2010Eur Neurol 2010; 64:236-40
Yildiz Murat, Tettenborn Barbara, Putzki Norman
Natalizumab treatment in paediatric multiple sclerosis: a case of induction, de-escalation and escalation
Putzki N, Stich O, Gartzen K, Kastrup O, Tettenborn B, Rauer S. Natalizumab treatment in paediatric multiple sclerosis: a case of induction, de-escalation and escalation. Eur J Neurol 2010; 17:e105.
16.08.2010Natalizumab treatment in paediatric multiple sclerosis: a case of induction, de-escalation and escalation
16.08.2010Eur J Neurol 2010; 17:e105
Putzki Norman, Stich Oliver, Gartzen Kristina, Kastrup Oliver, Tettenborn Barbara, Rauer Sebastian
Headache in multiple sclerosis
Putzki N, Katsarava Z. Headache in multiple sclerosis. Curr Pain Headache Rep 2010; 14:316-20.
01.08.2010Headache in multiple sclerosis
01.08.2010Curr Pain Headache Rep 2010; 14:316-20
Putzki Norman, Katsarava Zaza
Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
Tettenborn B, Putzki N, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Maschke M, Limmroth V. Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. Eur J Neurol 2010; 17 (1):31-7.
07.06.2010Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
07.06.2010Eur J Neurol 2010; 17 (1):31-7
Tettenborn Barbara, Putzki Norman, Yaldizli Oezguer, Mäurer M, Cursiefen S, Kuckert S, Maschke M, Limmroth V
Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
Putzki N, Baranwal M, Tettenborn B, Limmroth V, Kreuzfelder E. Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells. Eur Neurol 2010; 63:311-317.
05.05.2010Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
05.05.2010Eur Neurol 2010; 63:311-317
Putzki Norman, Baranwal Manoj Kumar, Tettenborn Barbara, Limmroth Volker, Kreuzfelder Ernst
Corpus callosum index and long-term disability in multiple sclerosis patients
Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N. Corpus callosum index and long-term disability in multiple sclerosis patients. J Neurol 2010; 257:1256-64.
03.03.2010Corpus callosum index and long-term disability in multiple sclerosis patients
03.03.2010J Neurol 2010; 257:1256-64
Yaldizli Ozgür, Atefy Ramin, Gass Achim, Sturm Dietrich, Glassl Stephanie, Tettenborn Barbara, Putzki Norman
Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
Putzki N, Yaldizli O, Bühler R, Schwegler G, Curtius D, Tettenborn B. Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland. Eur Neurol 2010; 63:101-106.
01.01.2010Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland
01.01.2010Eur Neurol 2010; 63:101-106
Putzki Norman, Yaldizli Ozgür, Bühler Robert, Schwegler Guido, Curtius Daniela, Tettenborn Barbara
Multiple sclerosis associated fatigue during natalizumab treatment
Putzki N, Yaldizli O, Tettenborn B, Diener H. Multiple sclerosis associated fatigue during natalizumab treatment. Journal of the neurological sciences 2009; 285:109-13.
15.10.2009Multiple sclerosis associated fatigue during natalizumab treatment
15.10.2009Journal of the neurological sciences 2009; 285:109-13
Putzki Norman, Yaldizli Ozgür, Tettenborn Barbara, Diener Hans Christoph
Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple Sclerosis
Yaldizli O, Kumar M, Vago S, Kreuzfelder E, Limmroth V, Putzki N. Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple Sclerosis. European neurology 2009; 62:321-326.
10.09.2009Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple Sclerosis
10.09.2009European neurology 2009; 62:321-326
Yaldizli Ozguer, Kumar Manoj, Vago Susanne, Kreuzfelder Erich, Limmroth Volker, Putzki Norman
Fatigue bei MS
Putzki N, Yaldizli O. Fatigue bei MS - CME Fortbildung. Der Neurologe und Psychiater (DNP) 2009; 8
24.08.2009Fatigue bei MS
24.08.2009Der Neurologe und Psychiater (DNP) 2009; 8
Putzki Norman, Yaldizli O
Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
Putzki N, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Klawe C, Maschke M, Tettenborn B, Limmroth V. Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009
09.07.2009Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries
09.07.2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009
Putzki Norman, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Klawe C, Maschke M, Tettenborn Barbara, Limmroth V
Spinal Pseudoathetosis in a patient with Multiple Sclerosis
Kägi G, Yaldizli O, Tettenborn B, Putzki N (2009). Spinal Pseudoathetosis in a patient with Multiple Sclerosis. Präsentiert bei: 182th Meeting of the Swiss Neurological Society, Interlaken
06.06.2009Spinal Pseudoathetosis in a patient with Multiple Sclerosis
06.06.2009182th Meeting of the Swiss Neurological Society
Kägi Georg, Yaldizli Oezguer, Tettenborn Barbara, Putzki Norman
Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis
Putzki N. Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:713-20.
01.06.2009Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis
01.06.2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:713-20
Putzki Norman
Natalizumab and atypical naevi
Yaldizli O, Baumberger P, Putzki N. Natalizumab and atypical naevi. Annales de dermatologie et de vénéréologie 2009; 136:450-1.
01.05.2009Natalizumab and atypical naevi
01.05.2009Annales de dermatologie et de vénéréologie 2009; 136:450-1
Yaldizli O, Baumberger P, Putzki Norman